Man Group PLC Ab Cellera Biologics Inc. Transaction History

Man Group PLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$4.29 - $5.97 $3.31 Million - $4.61 Million	771,934 New	771,934 $3.5 Million
Q4 2022 Feb 14, 2023	SELL	$9.48 - $14.52 $3.41 Million - $5.23 Million	-359,944 Reduced 54.09%	305,478 $3.09 Million
Q3 2022 Nov 14, 2022	BUY	$9.2 - $13.68 $4.36 Million - $6.48 Million	473,623 Added 246.94%	665,422 $6.58 Million
Q2 2022 Aug 15, 2022	BUY	$5.72 - $10.65 $1.1 Million - $2.04 Million	191,799 New	191,799 $2.04 Million
Q4 2021 Feb 14, 2022	SELL	$12.99 - $17.73 $638,653 - $871,695	-49,165 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$14.85 - $21.34 $49,123 - $70,592	3,308 Added 7.21%	49,165 $985,000
Q2 2021 Aug 16, 2021	BUY	$20.19 - $34.17 $11,144 - $18,861	552 Added 1.22%	45,857 $1.01 Million
Q1 2021 May 17, 2021	BUY	$23.29 - $53.2 $1.06 Million - $2.41 Million	45,305 New	45,305 $1.54 Million

153

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $787M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.